Further, DIM stimulated p-AMPK-α and disrupted the mammalian target of rapamycin (mTOR) and MAPK signaling response to Ang II, confirms the amelioration of cardiac hypertrophy [144]. The gene discussed is MTOR; the disease is cardiac hypertrophy.